Cellectar Biosciences Inc (CLRB)

[Sunofwolf]

Looks like the cfo quit and a temp one is in place-Who should be fired-the CEO!

[Sunofwolf]

Thoeos CEO-She is facing 20 yrs+ in Jail!

[Sunofwolf]

Down every day-only going to Go to a dollar LOL!

[Sunofwolf]

welfare for a million dollar phony CEO!

[Sunofwolf]

send in SEC complaints

[Sunofwolf]

Turd only reason not a dollar, some stupid investors bought in CEO lies about developing a cure for cancer-not ever happening-snake oil is alive.

[Sunofwolf]

not really 200 million +market cap-whole different company. CEO Caruso or what ever is a drunk Bum that knows nothing on how to run a BIO tech company. the only thing this company does is reverse the stock when the stock goes below a dollar to stay on NASD. CEO screwed over every investor over the last couple of years.

[Crusader]

Up 130% today, sound familiar?

Similar to IHUB IN SOME WAYS:

https://www.cnbc.com/quotes/?symbol=MGNX&tab=profile

[Sunofwolf]

Why did the CEO stop making its main drug 131 in house that was a 100% reliable source? The CEO story to save money by out sourcing 131 to a unreliable source is down right stupid, but not if the real reason was to pay for expensive office in NJ for a few of his cronies-more money for him-investors are just someone to steal from.

[Sunofwolf]

this was a partial exemption, I see no proof that any 131 is actually being used in studies. Zero progress in the last year, only a couple claims of studies by like two people, how can anyone believe them with such little proof of progress if any?

[Crusader]

NOT TRUE anymore but

The clinical trials were delayed their progress for a few months last year by industry wide FDA regulation of imported radioactive substances:

https://www.cellectar.com/news-media/press-releases/detail/194/cellectar-announces-fda-grants-exemption-to-import-alert

[Sunofwolf]

14 Million dolor's and CEO can't seem to supply 131 for research-

[Sunofwolf]

CEO does nothing but steal from investors-gave zero back to investors,false-Lying claims on drugs and stopped putting out data,stop producing drugs in house-Ceo made over a million dollors plus added a million dollor office in NJ for three directors-this is a Fraud company doing Zero on solving cancer!

[Sunofwolf]

Oh Wow Ceo goes on a vacation in Florida and gives investors the bill-good show for him not for investors-!

[whytestocks]

News: $CLRB Cellectar Biosciences to Present at NobleConXV, Noble Capital Markets' Fifteenth Annual Investor Conference

FLORHAM PARK, N.J., Jan. 23, 2019 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced that James Caruso, presiden...

Find out more https://marketwirenews.com/news-releases/cellectar-biosciences-to-present-at-nobleconxv-noble-capital-markets-fifteenth-annual-investor-conference-7504398.html

[Sunofwolf]

If I buy it will go down-more sells to buys. YOu could have bought it at $1.22.

[Crusader]

WHAT WOULD YOU PAY TO LIVE

2 years longer?

Cellectar Biosciences Reports Median Survival of 22 Months in Ongoing Phase 1 Trial Evaluating CLR 131 for Relapsed/Refractory Multiple Myeloma
BY MT Newswires
— 4:06 PM ET 01/07/2019
04:06 PM EST, 01/07/2019 (MT Newswires) -- Cellectar Biosciences ( CLRB
Loading...
Loading...
) announced median overall survival (mOS) in cohorts 1 to 4 of the company's ongoing phase 1 clinical trial evaluating CLR 131 for the treatment of relapsed/refractory (R/R) multiple myeloma (MM).
The results showed mOS of 22 months among 15 patients, all of whom were heavily pretreated, averaging five prior lines of systemic therapy. Each patient in cohorts 1 to 4 of the dose-escalation study received a single 30-minute infusion of CLR 131.
"The median overall survival of 22 months in this heavily pretreated patient population is very encouraging. These are patients with limited therapeutic options and, unfortunately, face poor prognoses," said James Caruso, president and chief executive officer of Cellectar Biosciences ( CLRB
Loading...
Loading...
).
"The convenience afforded by CLR 131 delivered in only one or two doses as currently administered in our ongoing hematology studies makes it a far less intrusive regimen than other treatments that must be administered at regular dosing intervals. We believe extending mOS with a more patient-friendly dosing regimen provides both a distinctive product profile and the potential to provide beneficial patient outcomes even in later lines of therapy," Caruso added.
Price: 1.8600, Change: +0.1400, Percent Change: +8.14

[Crusader]

I bet clinical trials are progressing well,

Now that the radioactive element IS available again...bloody Government delay last year!

Yes, clinical trial progress is reportedly OUTSTANDING.

This company will monetize its efforts sooner than most think here.

REJECT DISINFORMATION AND DO YOUR OWN RESEARCH.

READ! TALK TO CLRB IR ...live long and prosper.

For example:

Cellectar Biosciences Reports Median Survival of 22 Months in Ongoing Phase 1 Trial Evaluating CLR 131 for Relapsed/Refractory Multiple Myeloma
BY MT Newswires
— 4:06 PM ET 01/07/2019
04:06 PM EST, 01/07/2019 (MT Newswires) -- Cellectar Biosciences ( CLRB
Loading...
Loading...
) announced median overall survival (mOS) in cohorts 1 to 4 of the company's ongoing phase 1 clinical trial evaluating CLR 131 for the treatment of relapsed/refractory (R/R) multiple myeloma (MM).
The results showed mOS of 22 months among 15 patients, all of whom were heavily pretreated, averaging five prior lines of systemic therapy. Each patient in cohorts 1 to 4 of the dose-escalation study received a single 30-minute infusion of CLR 131.
"The median overall survival of 22 months in this heavily pretreated patient population is very encouraging. These are patients with limited therapeutic options and, unfortunately, face poor prognoses," said James Caruso, president and chief executive officer of Cellectar Biosciences ( CLRB
Loading...
Loading...
).
"The convenience afforded by CLR 131 delivered in only one or two doses as currently administered in our ongoing hematology studies makes it a far less intrusive regimen than other treatments that must be administered at regular dosing intervals. We believe extending mOS with a more patient-friendly dosing regimen provides both a distinctive product profile and the potential to provide beneficial patient outcomes even in later lines of therapy," Caruso added.
Price: 1.8600, Change: +0.1400, Percent Change: +8.14

[Crusader]

I am buying before it’s too late,

Sonofwolf.

[Sunofwolf]

Insider trading again-isn't that Illegal !@@@@@@

[Sunofwolf]

CEO-Causo spends hundreds of thousands on himself on new NJ office and the only two directors left while stopping production on its main drug 131-CLRB use to make it themselves. Now a unreliable company in Canada only ships very small amounts due to incompetence according to the FDA! Is this a company you want to buy stock in? I am personally filing a complaint with the SEC. Investors lost 100% of their money in the last year!

[Sunofwolf]

Garbage Fake news rubbish-Fraud!End of story!

[Sunofwolf]

Phony Briefcase company-old tech-not being developed because a CEO would rather spend the money on a fancy NJ office for himself and two directors. CEO Paid himself 1.1 million while investors lost everything!

[Sunofwolf]

Where is all the data that investors paid for?-Nothing is what you get here except lost money!

[Sunofwolf]

nothing ever happens at these bio conference's-Could the CEO explain why the stock went down 100% in one year or why they stopped making 131 themselves or why they need such a expensive office in NJ or why he got paid over a million dollars for losing investors all their money?@@@@@@@@@@@@

[Crusader]

Before it is too late,

TO SAY IT: HAPPY NEW YEAR!

[Sunofwolf]

CEO paid by CLRB $1.1 million+and now a couple hundred thousands for a new fancy office in NJ in a 6 million dollar company. Did next to nothing of value all year with a 100% drop in value. Investors got robbed on fake promises the company was going to have some worth while data- nothing was worth the 20 million wasted by this group of asss holes in the last two years+!

[Sunofwolf]

Ya go buy some stock lose more LOL!

[Sunofwolf]

I did better putting dough in my closet than here LOL-I have lots of company though-one trillion dollars lost in the last month that could fund the whole government for the whole year. I just bought a fancy car- could have bought a new one if I didn't get robbed here with money to go on a long vacation- I quit!

[Rymankoly]

Sunwolf
Don't give up on the stock market, but make sure you have an exit plans and follow them.
We all lost money on stocks (and biotech were the worst over last several month), so make sure to diversify and cut losses early (and I need to learn to do the same)

Happy Holidays and to a better 2019 (but the market can continue to be brutal....)

[Sunofwolf]

Sue www.Piaba.org!never had the smallest chance of winning here!

[Sunofwolf]

stock market is not for me anymore-moved on to anything else

[Sunofwolf]

today would have been $1100 drop if I didn't sell all ready. the market went down just 2-3%, so why does it go down another 10% more than the whole market?

[Sunofwolf]

I will update you on the Lawyers to call!

[Sunofwolf]

Join me in Investors Law suit against the directors-they stole your money and did not spend it on developing cancer Drugs!

[Sunofwolf]

Investors money treated as Cancer Here! Snake oil company-YA they will cure nothing and take your money for goes to CEO's pocket!

[Sunofwolf]

Notice Mult Million CEO bought $2300 stock recently-is this a Joke? Guess it is-why bother!?????????@@@@@@@@@@@

[Sunofwolf]

Directors won't buy their own stock.

[Sunofwolf]

85%+ stolen investors money here-be Gone and never return!

[Sunofwolf]

done nothing all year except Steal people's money and the Directors got themselves a new Jersey office very nice paid by sukers- the 10Q is a fraud-doesn't even so how much Directors spent on them self's. The CEO stole 1.1+ Million dollars for himself then stopped making the Main drug 131 because its now made in Canada by a bunch of Goof balls and they failed to make any 131 most of the year. This CEO ran the company into the Ground every time Going to Landenburg in NYC for more Suker money-14.4 million dollars. A company now with just three directors sucking up every dollar has not produced anything of value to anyone except for themselves. Directors own next to nothing in stock. the CEO is such a Big Jerk he bought a whole 1000 of stock this year-what a asshole.

[Sunofwolf]

Happy Christmas if you have dough left.

[Sunofwolf]

sure the stock should move down,but not this much.Going below a dollar in two weeks-first thinking a month-not now.then the 1-10 reverse again. I don't think anyone other than Landenburg would touch this offering. Looks like the CFO is cooking the books to hide where the money is really going. Jap patent maybe $50,000 some studies maybe a few hundred thousand. The CEO makes over a million. It isn't adding up to 10 million.

[Sunofwolf]

I will not invest again-Just too many Liars Like CLRB,I am filing a complaint with the SEC-no company should be able to reverse its stock three times in three years. I don't believe the 10Q-I think the CEO with the help of the CFO is stealing money from these offering's around $20 million.

[Rymankoly]

The entire bio sector got crashed and the small ones got crashed the most.
Better to be on the sideline until the air is clear

[Sunofwolf]

these crooked directors are in big trouble!

[Sunofwolf]

stock in a briefcase LOL!Dust off the data LOL

[Sunofwolf]

25% loss or more in three days! 100% loss for the year!

[Sunofwolf]

We are there Robbed by three directors

[Sunofwolf]

Bail out of this turkey!

[Sunofwolf]

One month was $2.40 now $1.74 for a loss of 66 cents at that rate its going to be less than a dollar very soon! Maybe just a few weeks away!